|
|
|
|
LEADER |
02349nam a22003855i 4500 |
001 |
000293904 |
005 |
20211014110828.0 |
007 |
cr nn 008mamaa |
008 |
150428s2015 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319156309
|
024 |
7 |
|
|a 10.1007/978-3-319-15630-9
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Tryptophan Metabolism: Implications for Biological Processes, Health and Disease /
|c edited by Atilla Engin, Ayse Basak Engin.
|
250 |
|
|
|a 1st ed. 2015.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Humana,
|c 2015.
|
300 |
|
|
|a XI, 382 p. 21 illus., 17 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Molecular and Integrative Toxicology,
|
505 |
0 |
|
|a TRYPTOPHAN RELATED SIGNALING MOLECULES: TARGETS AND FUNCTIONS -- TRYPTOPHAN AND CELL DEATH -- TRYPTOPHAN AND NITRIC OXIDE IN ALLERGY.-Tryptophan metabolites: A microbial perspective -- THE ROLE OF L-TRYPTOPHAN KYNURENINE PATHWAY METABOLISM IN VARIOUS INFECTIOUS DISEASES: FOCUS ON INDOLEAMINE 2,3-DIOXYGENASE 1 -- EVALUATION OF TRYPTOPHAN METABOLISM IN CHRONIC IMMUNE ACTIVATION -- DIABETES AND TRYPTOPHAN METABOLISM -- 3-HYDROXYKYNURENIC ACID AND TYPE 2 DIABETES: IMPLICATIONS FOR AGING, OBESITY, DEPRESSION, PARKINSON’S DISEASE AND SCHIZOPHRENIA -- THERAPEUTICAL IMPLICATIONS OF MELATONIN IN ALZHEIMER´S AND PARKINSON´S DISEASES -- TRYPTOPHAN METABOLISM AND SLEEP -- TRYPTOPHAN IN MOLECULAR HEMATOPOIESIS -- NIGHT-SHIFTS AND MELATONIN: RELEVANCE TO AGE AND BREAST CANCER -- CHEMOTHERAPEUTIC AGENTS IN CANCER TREATMENT AND TRYPTOPHAN METABOLISM.-INDOLEAMINE 2,3-DIOXYGENASE-COMPETENT REGULATORY DENDRITIC CELLS AND THEIR ROLE IN ALLOIMMUNE REGULATION AND TRANSPLANT IMMUNE TOLERANCE -- WINE FLAVOR AND TRYPTOPHAN .
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
|
0 |
|a Metabolic diseases.
|
650 |
|
0 |
|a Immunology.
|
650 |
|
0 |
|a Medicine.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
650 |
2 |
4 |
|a Metabolic Diseases.
|
650 |
2 |
4 |
|a Immunology.
|
650 |
2 |
4 |
|a Biomedicine, general.
|
700 |
1 |
|
|a Engin, Atilla.
|e editor.
|
700 |
1 |
|
|a Engin, Ayse Basak.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|